Japan Tobacco, Inc. engages in the manufacture and sale of tobacco, pharmaceutical and processed food products. It operates through the following divisions: Japanese Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. The Japanese Domestic segment deals with the production and sale of tobacco products in domestic areas. The International Tobacco segment manufactures and markets tobacco products worldwide. The Pharmaceutical segment develops, manufactures, and sells prescription drugs. The Processed Food segment offers processed food, bakery products and seasonings. The company was founded on April 1, 1985 and is headquartered in Tokyo, Japan.

AstraZeneca has always believed in science, inspires infinite possibilities, and puts science at the top of all work. AstraZeneca's strategically important core treatment areas, and are committed to exploring pathogenic mechanisms, treatment methods, and innovative drugs, so that science can change people's lives and bring it to the medical industry Significant changes.

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Chiesi Farmaceutici SpA develops and markets pharmaceutical products. The firm specializes in research, development and production of drugs in respiratory dosage forms, such as metered-dose inhalers and sterile unit dose vials. The company was founded by Giacomo Chiesi in 1935 and is headquartered in Parma, Italy.

Vectura Delivery Devices Ltd., a subsidiary of Philip Morris International, Inc., is a company headquartered in Cambridge, UK, that engages in research, development and commercialisation of pharmaceutical products. The firm was founded in 2000.\nThe company says this about itself: The principal activity of the Company is that of research, development and commercialisation of pharmaceutical products and technologies and this is expected to continue for the foreseeable future.

Glaxo Group Ltd. operates through its subsidiary Glaxo Laboratories Ltd. that engages in the production of food products for infants such as Ostermilk, Complan, Casilan, Farex. Glaxo Group Ltd. was formerly known as Glaxo Laboratories Ltd. and changed its name to Glaxo Group Ltd. in 1962. The company is based in Brentford, United Kingdom. Glaxo Group Ltd. operates as a subsidiary of Glaxosmithkline plc.

MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Westlake Village, California, the company was founded in February 1991. However, its present form is a result of a 2003 merger of three companies owned by Alfred E. Mann, Pharmaceutical Discovery Corporation (PDC), the cancer vaccine developer CTL ImmunoTherapies, Inc., and its sister company Allecure Corp, which was developing a allergy vaccine technology. MannKind Corporation was named after its founder, Alfred Mann. One of the former companies, Pharmaceutical Discovery, was purchased in 2001 from Solomon Steiner; with that purchase MannKind acquired the Technosphere molecule and Medtone inhaler, upon which was developed its lead product, Afrezza (inhalable insulin).

MicroDose Therapeutx, Inc. develops drugs and other technologies for the pharmaceutical and biotechnology industries. The company was founded by Scott Fleming and Anand Gumaste in 1998 and is headquartered in Monmouth Junction, NJ.

Ivax Pharmaceuticals Ireland, part of Teva Pharmaceutical Industries Ltd., is an Irish company. The firm manufactures pharmaceutical products.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Part of Philip Morris International, Inc., Philip Morris Products SA is a company headquartered in Neuch?tel, Switzerland. The firm provides tobacco stemming and re drying services.

Kind Consumer Ltd. operates as a healthcare research and development company which focuses on the inhalation technologies. It offers Voke, Oxette, Evo, and Polykind products. The company was founded by Alexander Thomas Hearn in 2006 and is headquartered in London, the United Kingdom.

Vectura Ltd., part of Philip Morris International, Inc., is a British company located in Chippenham. The firm manufactures medical equipment. It was founded in 1983.\nThe company says this about itself: The principal activity of the Company is that of research, development and commercialisation of pharmaceutical products and technologies and this is expected to continue for the foreseeable future. Vectura Limited (the \"Company\") is a wholly-owned subsidiary of Vectura Group plc (\"Vectura\" or the \"Group\") which is the smallest and largest entity to consolidate the Company's results. The Company's immediate parent undertaking is Vectura Group Investments Limited.

3M Innovative Properties Co. acquires and manages intellectual property right. It engages in the acquisition and ownership of the intellectual property rights to the products designed and manufactured by its parent company 3M Corporation. The company was founded on May 10, 1999 and is headquartered in Roseville, MN.

Innovata Biomed Ltd., part of Philip Morris International, Inc., is a company headquartered in Edinburgh, UK, that engages in the research, development, and commercialization of respiratory drug delivery technologies.

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Dura Pharmaceuticals develops prescription pharmaceutical products for the treatment of allergies. The company developed two core products, including Albuterol Spiros, a mechanical inhaler administering asthma medication and Ceclor CD, an asthma antibiotic. The company was formerly known as Immunetech Pharmaceuticals, Inc. and changed its name to Dura Pharmaceuticals, Inc. in December 1991. Dura Pharmaceuticals was founded in 1981 and is based in San Diego, California.

JT International SA manufactures cigarettes and tobacco products. Its brands include Amadis, Arsenal, Aspen, Cabin, Caster, Contessa, Dorchester, Embassy, Frontier, Genghis Khan, Gold Coast, Camel, Magna, North Star, Peace, Prima, Sebven Stars, Mild Seven, Salem, Winston, Sportsman, Sweet Menthol, Vantage, Wave, Winchester and YSL. The company was founded in 1999 and is headquartered in Dagmersellen, Switzerland.